Referência de medicamentos
Selumetinib
Selumetinib is a medicine in the class oncology.
- Classe do medicamento: Oncology
Última atualização Fontes: US FDA label, EMA SmPC
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Pontos-chave
- Classe do medicamento
- Oncology
- Código ATC
- L01EE04
- Formas farmacêuticas comuns
- cápsula
- Concentrações comuns
- 25 mg
- Interações conhecidas
- 47 (Grave: 20 · Moderada: 24 · Leve: 3)
- Nomes comerciais
- 3
- Países e mercados
- 3
Como funciona
Selumetinib inhibits mitogen-activated protein kinase kinases 1 and 2 (MEK1/2), upstream regulators of the ERK pathway. In NF1 mouse models it inhibited ERK phosphorylation and reduced neurofibroma numbers, volume and proliferation.
Dose habitual em adultos (resumo da bula)
NF1 with symptomatic, inoperable plexiform neurofibromas (capsules): 25 mg/m2 orally twice daily, swallowed whole, with or without food, by body surface area; until disease progression or unacceptable toxicity
Gravidez e amamentação
- Gravidez
- Unsafe Can cause fetal harm: in mice it caused embryo death, structural defects and lower fetal weight at over 5 times human exposure. No human data. Check pregnancy status; use effective contraception during and for 1 week after; it may weaken hormonal pills, so add a barrier method.
- Amamentação
- Unsafe No human milk data; it and its active metabolite reach mouse milk. LactMed: 98% protein bound, so milk levels are likely low. Because of possible infant toxicity, do not breastfeed during treatment and for 1 week after the last dose.
Efeitos adversos relatados
- Vomiting
- Diarrhea
- Increased creatine phosphokinase
- Dry skin
- Paronychia
- Nausea
Contraindicações
- None.
Quem deve ter cuidado
- Left ventricular dysfunction: assess ejection fraction before treatment, every 3 months in the first year, then every 6 months.
- Ocular toxicity (RVO, RPED, blurred vision): perform ophthalmic assessments; permanently discontinue for RVO.
- Gastrointestinal toxicity: start anti-diarrheal agent at first loose stool and increase fluids.
Informe ao farmacêutico ou ao médico sobre gravidez ou amamentação, doença renal ou hepática, alergias e todos os outros medicamentos ou suplementos que você usa.
Principais interações (47)
- Amobarbital + Selumetinib Major
- Apalutamide + Selumetinib Major
- Aprepitant + Selumetinib Major
- Carbamazepine + Selumetinib Major
- Chloramphenicol + Selumetinib Major
- Clarithromycin + Selumetinib Major
- Cyclosporin + Selumetinib Major
- Efavirenz + Selumetinib Major
- Enzalutamide + Selumetinib Major
- Fluconazole + Selumetinib Major
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para abrir a monografia completa de Selumetinib: doses, gravidez e amamentação, efeitos adversos, advertências e todas as interações.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
- IV preparation and dilution
Experimente o Pro+ grátis por 7 dias na web. Sem cartão.
Outros medicamentos desta classe
Perguntas frequentes
What is Selumetinib used for?
Selumetinib is a medicine in the class oncology.
What side effects have been reported with Selumetinib?
Vomiting, Diarrhea, Increased creatine phosphokinase, Dry skin, Paronychia, Nausea.
Can Selumetinib be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. Can cause fetal harm: in mice it caused embryo death, structural defects and lower fetal weight at over 5 times human exposure. No human data. Check pregnancy status; use effective contraception during and for 1 week after; it may weaken hormonal pills, so add a barrier method. Breastfeeding: Unsafe. No human milk data; it and its active metabolite reach mouse milk. LactMed: 98% protein bound, so milk levels are likely low. Because of possible infant toxicity, do not breastfeed during treatment and for 1 week after the last dose.
What does Selumetinib interact with?
MediHelp lists 47 known interactions for Selumetinib. Major: 20 · Moderate: 24 · Minor: 3. The most serious include Amobarbital, Apalutamide, Aprepitant.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
